FMC Corporation Q2 2025 Earnings Recap

FMC Q2 2025 August 1, 2025

FMC Corporation delivered solid second quarter results with adjusted EBITDA of $207 million and adjusted EPS of $0.69, slightly exceeding guidance. The company is transitioning its operations in India while focusing on growth opportunities in key markets.

Earnings Per Share Beat

$0.69 vs $0.59 est.

+16.9% surprise

Revenue Beat

1050500000 vs 996126140 est.

+5.5% surprise

Market Reaction

1-Day -0.79%

5-Day -5.84%

30-Day -2.5%

Key Takeaways

Sales increased 1% year-over-year, supported by a 6% volume growth amidst completed channel destocking.
Adjusted EBITDA rose 2% compared to the prior year due to lower costs and improved fixed cost absorption.
Upcoming product launches, including fluindapyr and pheromones, are set to enhance growth in the second half of 2025.
The company plans to divest its commercial operations in India to streamline operations and improve working capital efficiency.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit FMC on AllInvestView.

Next Q3 2025